Eli Lilly gears up for donanemab adcomm as FDA ponders changes to format
AstraZeneca invests $140M in Cellectis, secures 44% stake in CAR-T specialist
As drug shortages reach record highs, regulators weigh next steps
Boehringer raises hope of diabetic macular ischemia therapy
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
AstraZeneca invests $140M in Cellectis, secures 44% stake in CAR-T specialist
As drug shortages reach record highs, regulators weigh next steps
Boehringer raises hope of diabetic macular ischemia therapy
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud